| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 183.90M | — |
| Operating expense | — | — |
| Net income | 30.35M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AMPH returned -29.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -19.5% |
| 1 year | -29.3% |
| 5 years | +9.7% |
| 10 years | +13.5% |
| All-time high | $61.85 (Dec 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AMPH would be worth today ›No. Amphastar Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Amphastar Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol AMPH.
Amphastar Pharmaceuticals, Inc. is part of the Healthcare sector.
Amphastar Pharmaceuticals, Inc. has a market cap of 917.33M USD, based on the latest quote.
Amphastar Pharmaceuticals, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
